immunomodulator


Also found in: Medical, Wikipedia.

immunomodulator

(ˌɪmjʊnəʊˈmɒdjʊˌleɪtə)
n
a substance that affects the functioning of the immune system
Mentioned in ?
References in periodicals archive ?
Samcyprone, a proprietary topical formulation of the small molecule diphenylcyclopropenone (DCPC), is a topical immunomodulator that works by initiating a T-cell response.
Biotechnology company iBio (NYSE MKT:IBIO) reported on Monday the receipt of the new Canadian plague patent under its iBioModulator thermostable immunomodulator protein portfolio.
demonstrated that patients with CD who receive anti-TNF therapy combined with immunomodulator (s) have diminished pneumococcal antibody responses especially for serotypes 6B, 9V, 14F, and 19F, which are responsible for about 80% of invasive pneumococcal disease as compared with healthy controls and nonimmunosuppressed subjects with IBD.
The researchers in the international, multi-center SONIC (Study of Biologic and Immunomodulator Naive Patients in Crohn's Disease) study recruited 508 patients with Crohn's disease who were naive to immunomodulator drugs.
Orlando -- Infliximab therapy was a successful bridge to immunomodulator therapy in about one-third of children with Crohn's disease, based on an analysis of patient registry data reported in a poster presentation at the annual meeting of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition.
A conservative interpretation of our data is that IBD patients who receive immunomodulator medications are at higher risk of lymphoma than the general population, and that this increased risk could be due to the medication, disease activity, or both," the investigators wrote (Gut 2005;54:1121-5).
However, many patients, including those in the study, are unable to taper off steroids, even when receiving immunomodulator therapy.
What are the current growth drivers in the global immunomodulator market?
Patients received one single infusion of cyclophosphamide (CY) as immunomodulator prior to the first vaccination with IMA910.
This is a great opportunity for IRX Therapeutics to work with one of the leading developers of cancer therapies to further our understanding of the action of our novel immunomodulator, IRX-2.
IRX-2 Immunomodulator Selected for Use in Proof-of-Concept Clinical Trials in Multiple Cancer Indications